Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.
In this episode of the Inclusive Excellence Podcast, Erin Sember-Chase and Toral Patel invite C Lucas, wellness community programming specialist at Cornell, for a conversation about the challenges and complexities that exist in the fitness industry.
The financial stability of providers and their ability to serve patients is being threatened by Wall Street, according to new research co-authored by ILR Professor Rose Batt.
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the U.S. Department of Health and Human Services to study whether a bilingual video game can increase the use of contraception among Black and Hispanic adolescents.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
An analysis of beeswax in managed honeybee hives in New York finds a wide variety of pesticide, herbicide and fungicide residues, exposing current and future generations of bees to long-term toxicity.
In response to the COVID-19 pandemic, faculty in Cornell’s Public Health Program developed an innovative online training program to help boost skills in the public health workforce. A recent study recently reports that 94% of participants gained skills and knowledge they could apply directly to their work, and 86% developed a better understanding of public health.
Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.
An American Heart Association Presidential Advisory outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.
A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.